The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
The inspection classification was determined by the agency as Voluntary Action Indicated
This approval has come from the company's finished dosage form manufacturing facility
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Subscribe To Our Newsletter & Stay Updated
